Trial Profile
Phase II Study of MGI-114 [irofulven] in Patients With Metastatic Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2007
Price :
$35
*
At a glance
- Drugs Irofulven (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Oct 2007 Status change from in progress to completed
- 16 Sep 2005 New trial record.